A limitation of the present study is that it involved only correlative observations of the relationship between Derlin-1 expression and clinicopathological parameters in bladder cancer and lacked direct evidence regarding the function and underlying mechanism of the effects of Derlin-1. The gene discussed is DERL1; the disease is urinary bladder cancer.